130 related articles for article (PubMed ID: 11490102)
1. Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients.
Del Ser T; Barba R; Herranz AS; Seijas V; López-Manglano C; Domingo J; Pondal M
Cerebrovasc Dis; 2001 Aug; 12(2):91-8. PubMed ID: 11490102
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.
Tan NC; Venketasubramanian N; Saw SM; Tjia HT
Stroke; 2002 Aug; 33(8):1956-62. PubMed ID: 12154245
[TBL] [Abstract][Full Text] [Related]
3. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
Manns BJ; Burgess ED; Hyndman ME; Parsons HG; Schaefer JP; Scott-Douglas NW
Am J Kidney Dis; 1999 Oct; 34(4):669-77. PubMed ID: 10516348
[TBL] [Abstract][Full Text] [Related]
4. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
[TBL] [Abstract][Full Text] [Related]
5. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
Beaumont V; Malinow MR; Sexton G; Wilson D; Lemort N; Upson B; Beaumont JL
Atherosclerosis; 1992 Jun; 94(2-3):147-52. PubMed ID: 1632868
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocyst(e)inemia--determining factors and treatment.
Genest J
Can J Cardiol; 1999 Apr; 15 Suppl B():35B-38B. PubMed ID: 10350684
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
Weger M; Stanger O; Deutschmann H; Temmel W; Renner W; Schmut O; Semmelrock J; Haas A
Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Yoo JH; Lee SC
Atherosclerosis; 2001 Oct; 158(2):425-30. PubMed ID: 11583722
[TBL] [Abstract][Full Text] [Related]
9. Hyperhomocyst(e)inemia: a risk factor for cerebrovascular disease.
Parnetti L; Caso V; Amici S; Lanari A; Gallai V; Bottiglieri T
Clin Exp Hypertens; 2002; 24(7-8):501-9. PubMed ID: 12450225
[TBL] [Abstract][Full Text] [Related]
10. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
Yoo JH; Chung CS; Kang SS
Stroke; 1998 Dec; 29(12):2478-83. PubMed ID: 9836754
[TBL] [Abstract][Full Text] [Related]
11. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P
Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
[TBL] [Abstract][Full Text] [Related]
12. Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans.
Yoo JH; Park JE; Hong KP; Lee SH; Kim DK; Lee WR; Park SC
Thromb Res; 1999 Apr; 94(1):45-52. PubMed ID: 10213180
[TBL] [Abstract][Full Text] [Related]
13. Hyperhomocyst(e)inemia is associated with carotid atherosclerosis.
Lupattelli G; Rufini S; Locati EH; Lombardini R; Ciuffetti G; Siepi D; Mannarino E
Angiology; 1999 Oct; 50(10):823-30. PubMed ID: 10535721
[TBL] [Abstract][Full Text] [Related]
14. Hyperhomocyst(e)inemia induces multiorgan damage.
Miller A; Mujumdar V; Shek E; Guillot J; Angelo M; Palmer L; Tyagi SC
Heart Vessels; 2000; 15(3):135-43. PubMed ID: 11289502
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocyst(e)inaemia, but not MTHFR C677T mutation, as a risk factor for non-arteritic ischaemic optic neuropathy.
Weger M; Stanger O; Deutschmann H; Simon M; Renner W; Schmut O; Semmelrock J; Haas A
Br J Ophthalmol; 2001 Jul; 85(7):803-6. PubMed ID: 11423453
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.
Stanger OH; Semmelrock HJ; Rehak P; Tiran B; Meinitzer A; Rigler B; Tiran A
Atherosclerosis; 2002 May; 162(1):157-62. PubMed ID: 11947909
[TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
Stühlinger MC; Stanger O
Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
[TBL] [Abstract][Full Text] [Related]
18. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
Sydow K; Schwedhelm E; Arakawa N; Bode-Böger SM; Tsikas D; Hornig B; Frölich JC; Böger RH
Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
[TBL] [Abstract][Full Text] [Related]
19. Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms.
Delport R; Lingenhel AW; Ubbink JB; Kraft HG
Cardiovasc J S Afr; 2004; 15(5):207-13. PubMed ID: 15483732
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity of thermolabile methylenetetrahydrofolate reductase for vascular dementia.
Yoo JH; Choi GD; Kang SS
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1921-5. PubMed ID: 10938012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
